The influence of B-cell lymphoma 2 protein, an antiapoptotic regulator of mitochondrial permeability transition, on isoflurane-induced and ischemic postconditioning in rabbits

Anesthesia and Analgesia
Chen WangPaul S Pagel

Abstract

Brief exposure to isoflurane or repetitive, transient ischemia during early reperfusion after prolonged coronary artery occlusion protects against myocardial infarction by inhibiting the mitochondrial permeability transition pore (mPTP). Inhibition of mPTP during delayed ischemic preconditioning occurred concomitant with enhanced expression of the antiapoptotic protein B cell lymphoma-2 (Bcl-2). We tested the hypothesis that Bcl-2 mediates myocardial protection by isoflurane or brief ischemic episodes during reperfusion in rabbits (n = 91) subjected to a 30-min left anterior descending coronary artery occlusion followed by 3 h reperfusion. Rabbits received 0.9% saline, isoflurane (0.5 or 1.0 minimum alveolar concentration, MAC) administered for 3 min before and 2 min after reperfusion, 3 cycles of postconditioning ischemia (10 or 20 s each) during early reperfusion, 0.5 MAC isoflurane plus 3 cycles of postconditioning ischemia (10 s), or the direct mPTP inhibitor cyclosporin A (CsA, 10 mg/kg) in the presence or absence of the selective Bcl-2 inhibitor HA14-1 (2 mg/kg, i.p.). Isoflurane (1.0, but not 0.5, MAC) and postconditioning ischemia (20 s but not 10 s) significantly (P < 0.05) reduced infarct size (mean +/- sd, 21% +/- 4%...Continue Reading

References

Nov 1, 1981·Journal of Pharmacological Methods·D C WarltierH L Brooks
Apr 1, 1995·The Biochemical Journal·E J Griffiths, A P Halestrap
Apr 1, 1996·Journal of Bioenergetics and Biomembranes·P Bernardi, V Petronilli
Nov 5, 1997·The Journal of Biological Chemistry·M AritomiK Morikawa
Sep 12, 1998·Science·J M Adams, S Cory
Nov 24, 1999·Circulation·W HarringerA Haverich
Dec 10, 1999·Nature Cell Biology·M G Vander Heiden, C B Thompson
Mar 23, 2000·Cardiovascular Research·Z Q ZhaoJ Vinten-Johansen
May 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·R Foyouzi-YoussefiK H Krause
Jun 22, 2000·Proceedings of the National Academy of Sciences of the United States of America·J L WangZ Huang
Apr 12, 2001·American Journal of Physiology. Heart and Circulatory Physiology·Z ChenB H Chua
Jul 16, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Zhi-Qing ZhaoJakob Vinten-Johansen
Mar 11, 2004·Journal of Molecular and Cellular Cardiology·Xi-Ming YangMichael V Cohen
Jan 12, 2005·Circulation·Laurent ArgaudMichel Ovize
Feb 9, 2005·Journal of Molecular and Cellular Cardiology·Laurent ArgaudMichel Ovize
May 26, 2005·Pharmacological Reviews·Ute Fischer, Klaus Schulze-Osthoff
Sep 28, 2005·Circulation·Patrick StaatMichel Ovize
Jan 26, 2006·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·John G KrolikowskiPaul S Pagel

❮ Previous
Next ❯

Citations

Jun 2, 2007·Heart Failure Reviews·Derek J Hausenloy, Derek M Yellon
Aug 21, 2013·Heart, Lung & Circulation·Bentong Yu, Baoquan Song
Sep 19, 2007·Expert Opinion on Emerging Drugs·Eric R Gross, Garrett J Gross
Oct 5, 2010·The Journal of Thoracic and Cardiovascular Surgery·Chung Ho LeungChristopher A Caldarone
Jan 21, 2016·Oxidative Medicine and Cellular Longevity·Daoxu QuDong Wang
Aug 8, 2007·Pharmacology & Therapeutics·Derek J Hausenloy, Derek M Yellon
Apr 5, 2016·The Journal of Medical Investigation : JMI·Michiko KinoshitaKatsuya Tanaka
Feb 17, 2009·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·K A MockfordS Homer-Vanniasinkam
Oct 23, 2013·Asian Pacific Journal of Tropical Medicine·Xiao LiuYang Yang
Oct 4, 2014·Frontiers in Physiology·Bhawana AgarwalAmadou K S Camara
May 4, 2010·Journal of Cardiovascular Pharmacology and Therapeutics·Lars O KarlssonLars Grip
Jul 11, 2006·Current Opinion in Anaesthesiology·Phillip F PrattDavid C Warltier
Apr 16, 2009·European Journal of Anaesthesiology·Fengjiang ZhangMin Yan
Aug 14, 2009·Fundamental & Clinical Pharmacology·Shaminder KaurNirmal Singh
Jul 21, 2007·The Journal of Pharmacology and Experimental Therapeutics·Fatou Nsoure ObameDidier Morin
Jun 4, 2020·Journal of Cellular and Molecular Medicine·Derek J HausenloyFabio Di Lisa
Apr 11, 2018·Frontiers in Physiology·Pasquale PagliaroClaudia Penna
Apr 4, 2021·International Journal of Molecular Sciences·Gertrude J Nieuwenhuijs-MoekeHenri G D Leuvenink

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.